With the in-depth study of the mechanism for driver genes in lung cancer with brain metastasis, driver gene-associated signaling pathways, such as RAS/RAF, PI3K/AKT/mTOR, WNT/β-catenin, and JAK/STAT, also provide new targets for the treatment of lung cancer with brain metastases. This evidence concerns the gene SOAT1 and lung carcinoma.